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Abstract We have identified a splice variant of human
neutrophil collagenase (MMP-8) transcript (MMP-8alt) that
has a 91 bp insertion between codons for amino acid residues 34
and 35 of MMP-8 cDNA. This splice variant encodes an open
reading frame for a 444 residue protein, lacking a secretory
signal sequence. Our data suggested that, as opposed to the
original MMP-8, the translation product of MMP-8alt is not a
secreted protein; nevertheless, it is enzymatically active. Further
studies aimed at identifying the physiological substrates of
MMP-8alt protein may lead to uncover novel roles it plays in
cellular physiology.
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1. Introduction
Pre-mRNA splicing is a widely used biological mechanism
in higher eukaryotes for generating mature mRNA. More
recently, it has become apparent that pre-mRNAs of many
genes are capable of undergoing alternative splicing and gen-
erate multiple species of mature mRNA. Some of the splice
variants occur at the non-coding region of the mRNA and do
not in£uence the amino acid sequence of the translation prod-
ucts but may somehow a¡ect translation e⁄ciency [1]. On the
other hand, alternative splicings can also occur at the coding
region of the mRNA, resulting in translation products with
di¡erent tissue distribution or subcellular localization [2^4].
The ability to detect such splicing variants for a given
mRNA has greatly increased due to the use of polymerase
chain reaction (PCR) coupled with the reverse transcription
(RT) of mRNA.
Neutrophil collagenase (MMP-8) is a member of the matrix
metalloproteinase (MMP) family. It is capable of cleaving all
three K-chains of types I, II, and III collagen. It is a secreted
glycoprotein which is synthesized as a latent enzyme. The
activation of this enzyme requires autolytic removal of 80
amino acids from the N-terminus [5,6]. MMP-8 was previ-
ously thought to be expressed exclusively by neutrophils,
but recently its expression has also been detected in chondro-
cytes and was found to be capable of cleaving aggrecan in
cartilage [7^9]. In the process of analyzing the expression of
MMP-8 in di¡erent cell types, we identi¢ed a splice variant of
human MMP-8. Here we report the initial characterization of
this splice variant.
2. Materials and methods
2.1. Cell culture
Two monocytic cell lines, U937 and THP-1 cells, were maintained
in RPMI 1640 medium with 10% fetal bovine serum (Life Technolo-
gies, Inc.). Human chondrocytes were prepared from cartilage taken
from patients undergoing joint replacement as described [10] and cul-
tured in Dulbecco’s modi¢ed medium with 10% fetal bovine serum.
2.2. cDNA and genomic DNA cloning
Total RNA isolation from THP-1 cells, U937 cells and human
chondrocytes was accomplished using TriZol reagent (Life Technolo-
gies, Inc.). The RNA was reverse transcribed using the 1st Strand
cDNA Synthesis Kit (Life Technologies, Inc.) and oligo-dT primer.
PCR ampli¢cation of MMP-8 cDNA fragment corresponding to nu-
cleotides 68^850 of the published sequence (GenBank accession num-
ber J05556) was performed with Pfu polymerase (Stratagene) for 30
cycles (95‡C, 1 min; 55‡C, 2 min; 72‡C, 3 min) using primer pair A/B
(A, sense: AATGG TACCG ATCAT GTTCT CCCTG AAGA; B,
antisense: ATGGC CTGAA TTCCA TCGAT GTCA). A genomic
DNA fragment containing the nucleotide sequence between 101 and
250 of the MMP-8 cDNA was generated by PCR with Taq polymer-
ase (PE Applied Biosystems) for 30 cycles (95‡C, 1 min; 54‡C, 2 min;
72‡C, 3 min with 3 s extension after each cycle) using primer pair C/D
(C, sense: GCTCT TACTC CATGT GCA; D, antisense: ACGAT
CACAT TAGTG CCA). The relative position of the 91 bp exon
generated by alternative splicing within the intron was determined
by PCR using primer pair D/E (E, sense: CTACA GTAGT GAAGA
GGA). cDNAs containing the entire protein coding region of MMP-8
and MMP-8 alternatively spliced form, MMP-8alt, were generated by
RT-PCR and cloned into the Asp718/BamHI sites of pcDNA3+ vec-
tor (Invitrogen). DNA was sequenced using the dideoxy-mediated
chain termination method of Sanger et al. with a Sequenase 2.0 kit
(United States Biochemical).
2.3. In vitro translation of MMP-8 and MMP-8 activation
In vitro translation of MMP-8 cDNA subcloned into pCDNA3+
vector was accomplished using TNT T7 Coupled Reticulocyte Lysate
System (Promega) with [35S]methionine (Amersham). In certain cases,
canine pancreatic microsomal membranes (Promega) were also in-
cluded in the in vitro translation reaction to detect co-translational
processing and glycosylation. For studying MMP-8 autoactivation,
samples of in vitro translated proteins (50 Wl) were diluted to 1 ml
with 50 mM Tris-HCl, pH 7.5, 0.2 mM NaCl, 10 mM CaCl2, and 50
WM ZnCl2, and concentrated with a Centricon 10 (Amicon) to a ¢nal
volume of 50 Wl. Samples were then diluted 10-fold with the same
bu¡er containing 0.05% Brij-35 and were activated by treatment
with 2 mM p-aminophenylmercuric acetate for 90 min at 37‡C. In
vitro translated, 35S-labeled proteins were subjected to SDS-PAGE
and autoradiography.
3. Results
The nucleotide sequence of MMP-8 cDNA (GenBank ac-
cession number J05556) encodes a protein of 467 amino acids,
with a secretory signal sequence of 20 residues followed by the
prodomain of 80 residues. In the course of obtaining the N-
terminal fragment of MMP-8 cDNA from di¡erent cell types,
FEBS 21403 18-1-99
0014-5793/99/$19.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 1 6 5 4 - 8
*Corresponding author. Fax: (1) (908) 277-4739.
E-mail: shouih.hu@pharma.novartis.com
1Present address: Drug Discovery, The R.W. Johnson Pharmaceutical
Research Institute, Welsh and Mckean Rds, Spring House, PA 19477,
USA.
FEBS 21403FEBS Letters 443 (1999) 8^10
we identi¢ed two distinct DNA fragments from human U937
cells by RT-PCR using primers A and B. The sizes of these
two fragments are V780 bp and V870 bp, respectively (Fig.
1). These two PCR products were recovered and sequenced.
The V780 bp fragment matches exactly the corresponding
MMP-8 cDNA sequence in GenBank, whereas the V870 bp
fragment contains an additional 91 bp between residues 173
and 174 of the published sequence, as shown in Fig. 2A. This
additional segment of the transcript may be the result of an
alternative splicing of the MMP-8 pre-mRNA.
To identify the potential intronic sequence of the genomic
DNA which corresponds to the cDNA insert of MMP-8, we
utilized primers C and D to amplify the genomic DNA. These
two primers are located at the 5P side and the 3P side of the 91
bp insert, respectively. A 2.5 kb DNA fragment was generated
from the reaction. This 2.5 kb fragment contains an intron
about 2.3 kb in length which separates residues 173 and 174 of
the published cDNA sequence. The 91 bp sequence we iden-
ti¢ed was within this intronic sequence. In addition, the 91 bp
insert was immediately preceded by a consensus splice accep-
tor sequence, AG, at the 5P junction and immediately followed
by a consensus splice donor sequence, GT, at the 3P junction
(Fig. 2B). Therefore, this result clearly showed that the 91 bp
insertion was the result of alternative splicing of the pre-
mRNA to include an additional exon [11]. The two new in-
trons 5P and 3P of this 91 bp alternative exon are 1.9 kb and
360 bp, respectively.
This 91 bp insert interrupts amino acid residues 34 and 35
in the prodomain of the MMP-8 protein. All three possible
reading frames of this insert contain stop codons. One of them
has three stop codons followed by an ATG that is in frame
with the rest of MMP-8 coding sequence. The next potential
initiation codon is found at nucleotide 323, Met-85 of MMP-
8. To analyze the potential translation products of this alter-
natively spliced MMP-8 (MMP-8alt), cDNA encoding MMP-
8 and MMP-8alt were subjected to in vitro transcription and
translation. In vitro translated MMP-8 generated two major
products of approximately 53 kDa and 43 kDa (Fig. 3A). In
vitro translated MMP-8alt yielded two major products of ap-
proximately 49 kDa and 43 kDa (Fig. 3A). The 43 kDa prod-
uct in both cases is most likely a translation product starting
at Met-85 of MMP-8 and the corresponding methionine in
MMP-8alt. The 49 kDa protein would be the result of trans-
lation from the new methionine within the 91 bp insert.
Since the MMP-8 signal peptide is not part of the longest
open reading frame of the MMP-8alt transcript, MMP-8alt
should not be processed for secretion in the same way as
MMP-8. To verify this, the translation products were further
analyzed for co-translational processing and core glycosyla-
tion by the addition of canine pancreatic microsomal mem-
branes to the translation reaction. In vitro translation of
MMP-8 but not MMP-8alt in the presence of canine pancre-
atic microsomal membranes generated higher molecular
weight products (Fig. 3A). This result is in agreement with
the fact that MMP-8 but not MMP-8alt possesses a signal
sequence to translocate the protein into the microsomal mem-
branes for glycosylation.
Activation of MMPs requires the removal of the prodomain
from the protein by autolytic cleavage via a cysteine switch
activation mechanism [12]. This activation can also be
achieved in a test tube by treatment of MMPs with p-amino-
phenylmercuric acetate, which stimulates autolysis. The crit-
ical cysteine residue of MMP-8 is cysteine 91. This cysteine
residue is present in all three translation products mentioned
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Fig. 1. Analysis of the RT-PCR products generated from U937 cells
using primer pair A/B.
Fig. 2. Nucleotide sequence and genomic structure of MMP-8
around the 91 bp insert. A: Nucleotide sequence of the 5P 250 bp
of MMP-8 cDNA and the sequence of the 91 bp insert. The nucleo-
tide sequence of the 91 bp inset is shown in the box. Numeration
follows the published sequence. The putative new methionine initia-
tion codon for MMP-8alt is underlined and in boldface. B: Ge-
nomic organization of MMP-8 gene encodes two alternatively
spliced transcripts. Drawing shows splicing patterns that generate
MMP-8 and MMP-8alt transcripts. Open boxes represent exons,
and lines represent introns. Numbers indicate the postions in the
MMP-8 cDNA. Consensus splice donor/acceptor sites are under-
lined and in boldface.
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above. We found that upon treatment with p-aminophenyl-
mercuric acetate both in vitro translated MMP-8 and MMP-
8alt are converted to a 41 kDa form (Fig. 3B). This size
change is consistent with the size conversion of proenzyme
to the active enzyme. The 43 kDa internal translation product,
presumably amino acids 85^467 of MMP-8, is also converted
to the 41 kDa form (Fig. 3B).
4. Discussion
In the present study, we have identi¢ed an alternatively
spliced transcript of MMP-8, MMP-8alt. This version of the
MMP-8 transcript is the result of alternative splicing of a 2.3
kb intron that interrupts the codons for amino acids 34 and
35 of MMP-8 and encodes a potential protein of 444 residues
that lacks a secretory signal peptide. As a result, and unlike
MMP-8, MMP-8alt was not co-translationally processed in
the presence of canine microsomal membrane, even though
all the potential N-glycosylation sites are maintained in
MMP-8alt. It would thus be expected to be an intracellular
protein. Nevertheless, the protein generated from MMP-8alt
appears to be enzymatically active since autoactivation experi-
ments showed that protein generated from the MMP-8alt
transcript underwent autolysis to generate a protein with a
size consistent with the active form of MMP-8.
Recent studies have shown that MMP-8 is not a unique
gene product of neutrophils since it is also expressed by chon-
drocytes in human articular cartilage [8,9]. It is capable of
cleaving not only collagen but also aggrecan. In our study,
the alternatively spliced transcript of MMP-8 that we identi-
¢ed was also not unique to U937 cells. In addition, we de-
tected it in human chondrocytes and THP-1 cells by RT-PCR.
Since the protein product of this MMP-8alt transcript is most
likely located inside cells, it may use still other proteins as
substrates. Thus, the physiological role of MMP-8alt protein
remains to be determined.
Whether this alternatively spliced form of MMP is unique
for MMP-8 or occurs elsewhere in the MMP family is not
known at this time. Several members of MMP family whose
genomic structure have been analyzed all contain an intron at
the similar position as MMP-8 [13^15]. These include both
collagenase-1 (MMP-1) and collagenase-3 (MMP-13). In the
case of membrane-type MMPs, an extended family of MMP,
an alternatively spliced MT-MMP-3 was identi¢ed recently
[16]. This alternative splicing occurs near the transmembrane
region of MT-MMP-3, which results in soluble instead of
membrane-anchored MT-MMP-3. With the use of RT-PCR,
it is possible that more alternative spliced form of MMPs will
be identi¢ed. This new information may uncover novel roles
for MMPs in cellular physiology.
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Fig. 3. Analysis of in vitro translated MMP-8 and MMP-8alt. A:
In vitro translation of MMP-8 and MMP-8alt was carried out in
the absence or presence of indicated amounts of canine pancreatic
microsomal membranes (CPMM). B: In vitro translated MMP-8
and MMP-8alt were activated by treatment with p-aminophenylmer-
curic acetate (APMA). Lane 1, MMP-8; lane 2, MMP-8alt; lane 3,
MMP-8+2 mM APMA; lane 4, MMP-8alt+2 mM APMA.
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